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Abstract: The current review aimed to collect and critically analyze the scientific peer-reviewed
literature that is available about the use of digital applications for evaluation of visual parameters
in electronic devices (tablets and smartphones), confirming if there are studies calibrating and
validating each of these applications. Three bibliographic search engines (using the search equation
described in the paper) and the Mendeley reference manager search engine were used to complete the
analysis. Only articles written in English and that are evaluating the use of tests in healthy patients
to measure or characterize any visual function aspects using tablets or smartphones were included.
Articles using electronic visual tests to assess the results of surgical procedures or are conducted in
pathological conditions were excluded. A total of 19 articles meeting these inclusion and exclusion
criteria were finally analyzed. One critical point of all these studies is that there was no mention of
the characterization (spatial and/or colorimetrical) of screens and the stimuli used in most of them.
Only two studies described some level of calibration of the digital device before the beginning of the
study. Most revised articles described non-controlled comparatives studies (73.7%), reporting some
level of scientific evidence on the validation of tools, although more consistent studies are needed.
Keywords: visual function; app; electronic device; visual acuity; tablet; contrast sensitivity
1. Introduction
The evaluation of visual function is crucial in the clinical practice of eye care pro-
fessionals. This evaluation combines different tests characterizing the patient’s ability to
perceive and integrate external light stimuli captured by sight, with proper coordination of
both eyes’ visual systems [1,2]. In other words, the evaluation of visual function considers
the optical eye system’s imaging process and brain processing of information. In the clinical
setting, different aspects are evaluated in order to obtain complete information about the
visual system status, such as visual acuity (VA), contrast sensitivity (CS), binocular vision
(BV)—which in turn includes phorias, fusional vergences, or near point of convergence—
accommodation, or color vision [3]. All these evaluations are performed by clinicians using
different instruments and procedures that sometimes are time consuming and tiring for
the patient.
In the current digital era, the use of computers, smartphones, tablets, and smart-
watches is a typical daily practice, and there has been attempts to transfer theses usages
to the eye care professional’s clinical practice [1,2]. Only in 2016 in Spain, the National
Observatory of Telecommunications, and Information Society (ONTSI) reported that 85%
of Spanish internet users with ages ranging from 16 to 65 used social media for an average
of 1 h per day, and this included the usage of computers (91%), smartphones (95%), and
tablets (48%) [4]. Likewise, digital applications (apps) for different purposes have increased
exponentially in recent years [4]. Among these apps, those corresponding to the health
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field (e-health and m-health) are widely used [5]. Specifically, there are numerous apps
for evaluating different aspects of visual function that can be easily accessed via the App
Store (iOS) or Google Play store (android system). The use of these apps should be con-
ducted with care as no information about the scientific validation of these tools is normally
provided. Using non-validated apps in clinical settings to evaluate different aspects of the
visual function may result in incorrect clinical decisions [6].
Furthermore, significant discrepancies in image reproduction are present among
electronic devices. For example, previous research from our group has demonstrated large
color reproduction differences between smartphones (Samsung Galaxy S4 and iPhone 4s),
and tablets (Samsung Galaxy Tab 3 and iPad 4) [3]. Likewise, it has even been demonstrated
that there are significant differences in digital reproduction of visual stimuli among different
units of the same tablet model [7]. Therefore, it is worth asking to what extent is the use of
applications available in digital stores correct with respect to evaluating visual function.
Furthermore, in another recent study by our research group, the differences in luminance
reproduction between 20 tablets (Samsung Galaxy Tab A, SM-T519, 2019 version), as well as
their implications for contrast reproduction were evaluated, having as a result differences
between the devices even if they are from the same manufacturing batch [8]. Although
our study is based on applications for smartphones and tablets, it must be disregarded
that validation tests are also being carried out on virtual reality devices, as reported by the
study by Wroblewski et al. [9] that conducted a validation of the VirtualEye system (with
its respective characterization of screens: luminance measurement).
It is necessary to define two concepts for a better understanding of the validation of
the digital tools, the concepts of characterization and validation. Characterization is the
procedure that allows us to determine peculiar attributes of an object in our study of a
screen so that it is clearly distinguished from the others. Thus, the characterization ensures
that the designed test is reproduced in each device, because each one can have a different
reproduction. In contrast, validation is the procedure of providing firmness or certainty to
an action or theory. In our study, clinical validation refers to confirming that the object of
study (app) measures in a similar or comparable manner to the measures obtained with
the gold standard (traditional test). Ideally, both concepts should be linked, but one does
not exclude the other; they are complementary. If the screen of the device has not been
previously characterized, how can you be ensuring that the comparison with the gold
standard is reliable? At the very least, they cannot be considered to provide the same level
of scientific evidence [8,10,11].
In addition, an important point to consider in this type of study is the privacy of the
data, since these devices are using sensitive information of patients and must be properly
treated, according to the European or American regulations’ General Data Protection
Regulation (GDPR, 1995) and Protected Health Information (PHI) developed in the Health
Insurance Portability and Accountability Act (HIPAA, 1996). This is clearly detailed in the
scoping review conducted by Benjumea et al. [12] 2020 and Apple’s privacy section [13],
where the regulations for the Health App are detailed as well.
The current review aimed to collect and analyze critically the scientific peer-reviewed
literature that is available about the use of digital applications for the evaluation of visual
parameters in electronic devices (tablets and smartphones), confirming if there are studies
calibrating and validating each of these applications. To our knowledge, this is the first
review on this crucial aspect: the validity of visual function evaluation using validated
apps. It should be considered that some digital visual functions are being used in clinical
investigations without confirming that they are adequate for such evaluations. Therefore,
it is unknown if the validity of the results provided in these investigations are biased due
to the use of non-validated digital clinical tools.
2. Materials and Methods
Three bibliographic search engines (the utilization of the search equation is described
later in this paper) and the Mendeley reference manager search engine were used to
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complete the analysis. The following inclusion criteria were established in order to focus
the search and to delimit the results:
• Articles showing the use of tests in healthy patients to evaluate any aspect of the
visual function using tablets or smartphones;
• Articles written in English.
The exclusion criteria for the current review included articles using electronic visual
tests to evaluate the results of surgical procedures or in pathological conditions, studies
involving animals, and articles showing simulations or theoretical results. Before a more
detailed analysis in pathological cases, we preferred to focus our analysis on healthy eyes,
which is the most optimal situation as the potential bias of measurements may have a less
relevant impact on clinical decisions. Future analysis of the literature should be performed
in the future including pathological or post-surgical cases and considering the results of
this previous analysis in healthy eyes, with the aim to compare possible differences.
The search equation used for this review was as follows.
(“visual function” OR “visual acuity”) AND (“iPad” OR “app”) NOT (“Mice model”
OR “Animal model”) NOT (“Amblyopia treatment” OR “ocular diseases”)
The results obtained with this search equation was first filtered after reading the titles
and abstracts and considering the inclusion and exclusion criteria defined. The articles’
complete text that passed this first filter was obtained and read to confirm their explicit
inclusion or exclusion in the review. Finally, a qualitative assessment of the results obtained
was performed after classifying them by subject.
3. Results
3.1. Search Results
After searching on different platforms, a total of 248 articles were found (Figure 1).
Specifically, 54 potentially useful results were found in the first search in PubMed (per-
formed on 26 June 2019). On the same search date, 97 studies were found in the rest of the
search platforms used.
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Of all the articles found, 180 articles were excluded after verifying the first analysis
described above for they did not meet the inclusion criteria. In the second analysis of the
full text, 49 studies were excluded from the potentially eligible 68 articles (those previously
selected).
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3.2. Analysis of the Articles Included and Excluded
Table 1 summarizes the most relevant information of the articles finally included in
the current article [2,6,14–30].
Table 1. Summary of the most relevant information of the articles included in the current review.
Authors Sample Device Apps orApplications Measures Main Results and Conclusions








â With external glare source
reflecting over the iPad screen,
the iPad (EDTRS chart)
provided VA measurements
that were significantly worse
at an average of 0.18 logMAR








â VA median measurements
taken with iPad (Eye Chart
Pro): 0.40 logMAR
Kingsnorth










â ORS custom-made charts:
194 ± 29 wpm and
195 ± 25 wpm; ORS Radner
chart: 166 ± 20 wpm;
p < 0.001. Repeatability: app
charts: 0.30 ± 22.5 wpm














â VA mean unflanked:
0.0 logMAR
Manzanaro









between far VA measured
with iPad (2020 Duo FLEX
Visual Acuity Chart) and
measured with traditional
tests
â 4 m VA mean; iPad app: 0.093,
ETDRS: 0.165; p < 0.001; 2 m
VA mean; iPad app: −0.089,
ETDRS: −0.049; p = 0.016







VA (6 S VA chart)
â VA mean difference:
0.02 logMAR (95 % limit of
agreement)













â VA mean: EyeHand Book app:
0.1398 logMAR SD: 0.132;
Rosenbaun optotype: 0.234
logMAR; SD: 0.186
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Table 1. Cont.
Authors Sample Device Apps orApplications Measures Main Results and Conclusions
Kingsnorth








â Great repeatability of results
obtained with the Aston near
and Aston distance apps
compared to the CSV-100 test
but less than the Pelli–Robson
test
Pathipati












â VA logMAR average: Snellen:
0.211 ± 0.35; p = 0.00003 vs.
Paxos Checkup: 0.06 ± 0.40;
p = 0.264)






VA near and far
(ETDRS optotype
vs. app)
â VA measured with both
methods differed
significantly: they could not
be used interchangeably
â SightBook VA mean
difference: 5.4 letters (RE) and
6.1 letters (LE); Snellen VA
mean difference: 7.7 (RE) and
7.9 (LE)

















â New method not influenced
by the memory effect
â Mean logMAR differences:
Snellen E: −0.004, Tumbing E:
−0.03 and Landolt C: 0.04)
Rodriguez-








â App comparable with results
of OPTHEC6000
â Very practical in clinical use
for screening purposes
â VA mean differences:
0.06 logMAR (p < 0.001) and
CS mean differences: 0.05 log
units (p > 0.05)








â App easy to use, providing
results reliable
â First app with Korean
optotypes to evaluate reading
speed
â Mean reading speed:
202.3 ± 84.4 wpm and mean
reading and speaking speed
129.7 ± 25.9 wpm; p < 0.001
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Table 1. Cont.
Authors Sample Device Apps orApplications Measures Main Results and Conclusions
de Fez et al. [2]
2018
n = 407
participants iPad Optopad Color vision
â Comparable diagnostic ability
of color vision anomalies
compared to
Farnsworth–Munsell (FM
100 H) and Ishihara plates.
Bodduluri








â Games 1 and 2 and the
Cambridge Colour Test (CCT):
similar absolute thresholds
and tolerance intervals
â Game 3: significantly lower
values than games 1, 2, and
the CCT, due to visual task
differences









â Good correlation between app
and conventional optotypes
Brucker et al. [29]
2019
n = 120
participants iPad Odysight app
VA and CS (app vs.
ETDRS test)
â Optimal VA measurements
â CS results were not as reliable
Fernández









â Digital measurements quick
to do in the clinical setting
â Not interchangeable with
traditional ones
â VA logMAR mean: app:
−0.04 ± 0.09 and ETDRS:
−0.05 ± 0.08; p = 0.51. CS log
units mean: app: 0.83 ± 0.23
and CSF: 1.74 ± 0.019;
p < 0.001










review concluding that there
is a need to carry out app
validations in order to
corroborate their effectiveness
Abbreviations: VA, visual acuity; CS, contrast sensitivity; ETDRS, Early Treatment Diabetic Retinopathy Study; FM, Fansworth–Munsell.
A total of 49 articles were excluded from the review. Most of them showed a compari-
son between digital measurements of parameters, such as visual acuity, contrast sensitivity,
and reading speed, with traditional measurement methods, concluding that digital and
traditional measures could not be used interchangeably.
The following causes of exclusion were found for the excluded articles: unhealthy
patients and operated patients (40 works); analysis using animal models or human tissue
(5 articles); articles not written in English; or use of tablet simulations (3 works). Specifically,
of the 40 articles excluded due to unhealthy status or previous surgery, 25% were conducted
in low vision patients, 17.5% in amblyopic patients, 12.5% in age-related macular degenera-
tion (AMD) patients, and 7.5% in both diabetes and multiple sclerosis subjects. The rest
of the excluded cases (2.5%) include other pathological conditions: maculopathy, stroke,
retinoschisis, senile dementia, hemangiopericytoma, Parkinson, and albinism strabismus,
blindness, or dry eye.
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4. Discussion
Most of the articles finally included in this critical review of the existing scientific
literature on the use of digital devices for evaluating visual function (57.9%) reported the
use of evaluations of visual acuity: 10.5% for the assessment of reading speed, and 5.3%
(each) for the evaluation of contrast sensitivity and color vision, respectively. Likewise,
some articles report using digital applications to evaluate more than one aspect of the
visual function, with 5.3% of studies studying the entire visual function, including healthy
patients and those with ocular abnormalities. It is worth noting that, on average, the level
of evidence reported in all of these investigations is limited, with 73.7% of them being
comparatives studies, 5.3% being observational studies, and 5.3% being case reports. A
cross-sectional study, a bibliographic review, and a clinical trial (blind examiner) were
found and analyzed. More consistent studies should be designed and performed in order
to validate the great variety of digital apps that are currently available for the evaluation of
visual function. Comparative analyses in which the order of performance of tests (digital
and traditional) is assigned randomly, with clear descriptions of the calibration process of
screens and illumination conditions of the examination room, with an additional analysis
of reliability, and with different examiners performing digital and traditional tests should
be conducted. Indeed, at least one of these types of studies should have been conducted
for any app that was released before indicating the possibility of its clinical use.
As mentioned, one critical point of all these studies is that there is no mention or
partial description of the visualization conditions present during the measurements (ob-
servation distance, screen tilt, ambience illumination level, and screen brightness) or the
characterization (spatial and/or colorimetrical) of screens and the stimuli used in most of
them. Only the studies from de Fez et al. [2] and Rodriguez-Vallejo et al. [25] mentioned
that a previous characterization of the digital device used had been performed. Likewise,
it is not clear that digital apps evaluating contrast sensitivity have considered that the
concept of contrast should be based on luminance and not on a concept of the difference
of digital levels. The contrast defined considering the digital levels of a screen is not
equivalent to the classical definition of contrast considering luminance, the definition used
to calculate contrast sensitivity [3]. Therefore, in addition to improvement in the design
of the clinical studies for evaluating the clinical usefulness of digital apps for assessing
visual function, more information should be provided about the characterization of the
screens in order to know if the differences obtained between digital and traditional tests
may be due to problems of contrast and color reproduction of screens [3,7]. de Fez et al. [7]
performed spatial and colorimetric characterization of different devices using different
methods, demonstrating that mathematical adjustment methods such as gain-offset-gamma
(GOG) adjustments provide worse results in color reproduction than methods based on 3D
LUT tables. Furthermore, they find that another problem arises if a test designed colorimet-
rically for one device is presented on a different device. The digital levels of a stimulus
calculated for a given device can produce different chromaticities when reproduced in
another, because colorimetric characterization is device dependent. They found that on
iPad devices, color reproduction errors are below the minimum level distinguishable by
the human eye when using the device’s characterization data, but they can be more than
six times higher if this is not performed. This fact implies that vision tests (color vision;
CSF-Contrast Sensitivity Function) designed for a particular device can result in erroneous
diagnoses when administered in other devices, even those of the same model. As an
example, Black et al. [14] evaluated 85 patients in a blind examining clinical trial and found
that the “Visual Acuity XL” application used on an iPad device provided significantly
worse visual acuity measures (mean difference 0.18 logMAR) than those obtained with
traditional methods. The authors did not mention that this difference may be attributed to
screen reproduction errors or discrepancies in the stimuli’s conception and design.
Regarding the characterization of screens, it should be also mentioned that the re-
production of the chromaticity and/or the luminance of the stimulus may depend on its
position due to the inhomogeneity of the screen (this is another part of spatial charac-
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terization). A full-screen stimulus may not be perceived as uniform due to this lack of
homogeneity, and a stimulus at x degrees from the center may also be reproduced with
different characteristics than the same stimulus at -x degrees. If only a small and constant
area of the screen is to be used for the test in question, this part of the characterization
can be omitted. In terms of color reproduction, colorimetry covers both chromaticity and
luminance of color. A luminance-only characterization can be carried out if the stimulus
is achromatic, but it should be considered that while a white stimulus has a single lumi-
nance value to be measured and characterized, an achromatic stimulus has gray levels.
The use of a gamma curve is an approximation of luminance, which can be more or less
reliable depending on the behavior of the particular device. For example, a gamma curve
does not reproduce saturation at high power-on levels, as can happen on LCD and TFT
screens. In contrast, the use of 3DLUT tables, which also approximates luminance values
by interpolation can increase the reliability of the approximation [7,8].
As in the current review, Hogarty et al. [6] remarked in their bibliographic research
the relevance of using properly validated digital applications for any type of praxis with
patients, including the analysis of the entire visual function. This was a consistent conclu-
sion from this previous review, as any of the digital applications revised in this literature
search had proper validation. It should be noted that the use of non-validated digital apps
for evaluating visual parameters in any research can result in inaccurate conclusions and
subsequently to incorrect “scientific-based” clinical decisions. Indeed, new guidelines
should be defined in the future in order to classify or identify, in Google play and Apple
stores, whether an app can be used or not for clinical purposes according to scientific
validations associated with this technology. A specific type of signaling or labelling in the
store should be developed in order to avoid the inadequate use of apps in patients.
Despite the lack of information about the validation of apps and digital tests used in
most of revised articles, some of them analyzed the clinical equivalences between digital
and traditional tests, providing an evaluation or discussion of interchangeability between
them. Azis et al. [27] found in a sample of 195 patients aged between 5 and 6 years
that there was a good correlation between the results obtained using the “AAPOS Vision
Screening” application and those obtained with conventional optotypes (ETDRS and Lea
symbols). Specifically, the results obtained using the app (Lea symbols) to test visual acuity
by parents as a potential screening tool were compared to gold standard vision testing by
an optometrist using the Lea symbols chart. The authors concluded that the app evaluated
could be considered as a promising tool for visual acuity screening among Malaysian
preschool children. However, due to the specific type of population evaluated and the
scarcity of information about the tablet used and its level of calibration, the results obtained
cannot be extrapolated to the general population, but it can be considered as a first level of
validation of this app. Concerning the measurement of visual acuity with digital devices,
there is an additional aspect that must be considered. The minimum spatial detail available
for some electronic devices given their pixel size does not allow measuring hyperacuity
thresholds for close viewing distances. Therefore, many devices will not support visual
acuity beyond 6/6 (1 min arc detail, e.g., VR goggles) and they will not allow measuring
with reliability people with acuities down to 6/3 (0.5 min arc).
Rodríguez-Vallejo et al. [25] evaluated visual acuity and contrast sensitivity in 45 pa-
tients (Spanish adult university population) by employing a self-developed application that
was previously validated [31]. These authors measured the chromaticity of an iPad with
a retina display using the Spyder4Elite colorimeter and the luminosity of the room with
theLX1330B luxmeter. Likewise, the brightness of the screen was set at the maximum. Con-
cerning visual acuity, these authors compared the results of the visual acuity test of the app
that was based on the ATS (Amblyopia Treatment Study) procedure and HOTV optotypes
with the values obtained with the ETDRS chart projected on a screen (Optec 6500 system),
obtaining a mean difference of approximately three letters on a logMAR chart with five
letters per line. Moreover, the agreement between app and conventional test with respect to
reliability was evaluated by citing 25 subjects a total of two or more sessions that are spaced
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a week apart. Coefficients of reliability were 0.15 logMAR for our method and 0.17 logMAR
for the ETDRS testing protocol. In terms of contrast sensitivity, the mean differences be-
tween the app and the measures obtained with the Functional Acuity Contrast Test (FACT)
were lower than 0.05 log units for all spatial frequencies. The limits of agreement between
digital and traditional tests were higher for high spatial frequencies. According to these
authors, this finding was explained by the lower repeatability of both tests for those spatial
frequencies [25]. This study is one of the most complete validation of an app with respect
to evaluating some visual function parameters and should be considered when trying to
design a validation study for a specific app. They described the fact that the brightness of
the screen was set on the maximum level (342 cd/m2) was a limitation of their study, which
is over the recommended background luminance [25]. They describe as a potential solution
for this the future development of a system for measuring environmental illumination
and automatically setting up background luminance in accordance with the measured
value. Likewise, it should be considered that different levels of brightness were used on the
screens of Optec 6500 and the iPad. However, the contrast sensitivity results obtained were
equivalent, and this can be explained because doubling the luminance level improves one
letter on a test of five letters per row in the range of 40 cd/m2 to 600 cd/m2. Although the
contrast values on screens of different brightness are similar, the contrast threshold values
change with brightness are not similar depending on the spatial frequency [32]; therefore,
it is risky to state that the results are completely equivalent. In another study, Kollbaum
et al. [33] found results with an iPad-based letter contrast sensitivity test that agreed with
those obtained with the Freiburg Acuity and Contrast Test, but it was higher than those
measured with the Pelli–Robson Test. These results indicate that the app evaluated was an
efficient alternative for clinical use. This parameter was evaluated in 40 subjects (20 with
low vision and 20 healthy) in a monocular mode. Likewise, Habtamu et al. [34] developed
a new tumbling-E smartphone-based contrast sensitivity test (Peek Contrast Sensitivity,
PeekCS) and was compared with a tumbling-E Pelli–Robson contrast sensitivity test. These
authors found highly comparable results with both tests.
de Fez et al. [2] used the iPad application “Optopad,” designed to detect color vision
deficiencies in two different clinical studies in order to evaluate diagnostic precision.
First, a comparison with the Ishihara test was performed in 341 patients (children). A
second comparative study with the Farnsworth–Munsell test (FM 100 H) was conducted in
66 patients (university adult population). Previous characterization of the digital device
used was made, and the colorimetric adjustments required in the test were performed
using the MATLAB software (R2008a) [3,6]. No statistically significant differences were
found between “Optopad” and Isihara in detecting protan-deutan defects. When FM 100 H
and “Optopad” were compared, a clinically reasonable level of predictability of “Optopad”
data from the FM results was observed. Multiple regression analysis provided a regression
coefficient (R2) of 0.86, with 80% of cases with residuals less than 25 units [2]. This is the
second study of validation of a visual function test that provides a complete comparison
with conventional tests after a careful calibration of the screens used for the reproduction
of stimuli.
Another aspect of the visual function that can be measured with digital applications
is the reading speed. Kingsnorth et al. [16] compared reading speed measured by a
mobile application and the Radner reading test’s printed version in 21 patients with their
usual correction. These authors found that the measurement of reading speed using both
methods was not interchangeable. However, the authors concluded that the use of mobile
devices was reliable and fast to perform. Notwithstanding, this potential advantage is not
altogether valid if the data obtained with this application are not accurate enough.
Finally, a new app has been recently developed for the measurement of the defocus
curve with an iPad, which has become an essential clinical test for an adequate evaluation
of visual performance with any type of presbyopic correction, including cataract surgery
with the implantation of multifocal intraocular lenses [30]. These authors confirmed that
the measurement of the visual acuity defocus curve (VADC) showed good agreement
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with the ETDRS test and good repeatability (two consecutive measurements) despite the
short testing time, but it should be mentioned that this interchangeability analysis was
performed for visual acuity measures for the level of defocus of 0 D but not for the rest.
However, the repeatability of measurements of contrast sensitivity defocus curve (CSDC)
was around three times poorer than that obtained along the VADC. The authors concluded
that CSDC had to be optimized in the future in order to obtain more repeatable results. In
addition to these other articles have been published in recent years, showing the results
of the validity of some apps as screening tools used in the evaluation of the visual acuity
and visual field in different pathological conditions [35–37], but a previous validation in
healthy population is crucial.
As mentioned in the introduction part of this study, privacy is a fundamental aspect to
consider in the development and operation of a ‘health application,’ since highly sensitive
information from patients is used, which must be correctly treated following the current
regulation in place. In this manner, the study carried out by Turpin et al. [38] indicated
in 2014 that they were subject to American regulations (HIPAA 1996) and that their data
will only be uploaded to the cloud if the application (PsyPad) has an internet connection,
which shows consistency with the work developed by Benjumea et al. [12] in 2020.
Population selection bias is a critical factor for extrapolating the results of these investi-
gations to the general population, including aspects such as setting (26.3%
hospital [1,20,22,28,29], university 21.1% [2,14,18,25]), and ethnicity (26.3%) [15,23,24,26,27]
and age (15.8%) [17,20,29]. Likewise, there is a need in some studies to provide separate
and adequate description of materials (10.5%) [16,21]. Most of the studies did not report
the electronic device model used (commercial model and version of the tablet or iPad).
Only a certain level of characterization of the screen used for the generation of the stimuli
was performed in two of the studies. However, despite these limitations and the minimal
evidence of characterization of digital applications evaluating the visual function, they are
widely used in clinical practice and investigations, with the potential of extracting, in some
cases, inaccurate conclusions and decisions.
5. Conclusions
There are many apps that have been used and validated clinically for measuring
different aspects of visual function, such as visual acuity, contrast sensitivity, or color
vision. However, limited information is provided in the peer-reviewed literature about the
characterization of screens used for displaying stimuli. Therefore, it is not only crucial to
use an app validated clinically but also to provide information about the characterization
of the devices used for displaying stimuli. One app can be very well designed and
validated but used in an electronic device that cannot reproduce the stimuli reliably. For
this reason, the technical requirements in terms of screen characteristics must be also
provided, and information on how data privacy was obtained must be preserved according
to national and international regulations. Thus, an app that is valid for clinical purposes
should be validated, and the technical requirements for stimuli reproduction should be
well established, allowing the differentiation of well-developed apps from the numerous
applications that evaluate visual function and that are available in digital stores. As
we are healthcare personnel dealing with patients, the use of previously validated tools
(applications) should be mandatory in order to ensure that the results obtained are correct
or comparable with conventional methods.
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